Updated HCP Risk Review

Host Cell Proteins (HCPs) remain a major focus in biopharmaceutical manufacturing. In this article, we highlight a recently published industry review on HCP clinical safety and explore how evolving technologies are reshaping impurity profiling and risk assessment.